title: PC-1 (ENPP1) K121Q polymorphism in overweight and obese type 2 diabetic coronary heart disease patients.
abstract: OBJECTIVE
  The aim of the present study was to investigate the prevalence of the PC-1 121Q allele and to test its association to cardiovascular risk factors in type 2 diabetes mellitus (DM) patients.
  
  
  METHODS
  A total of 103 unrelated Caucasians from Serbia, including 71 DM patients without CHD (aged 59.4 +/- 8.9 years, with a mean body mass index (BMI) of 33.3 +/- 4.8 kg/m2) and 32 DM patients who suffered from coronary heart disease (DM+CHD) (aged 59.3 +/- 8.0 years, with a mean BMI of 30.37 +/- 3.71 kg/m2), were genotyped for PC-1 K121Q using a mutagenic separated PCR assay.
  
  
  RESULTS
  The prevalence of the PC-1 121Q allele was significantly higher in DM+CHD, compared to DM (P < 0.001) and control (P < 0.001) groups, since it was found in 10 (14%) DM patients, 13 (41%) DM+CHD patients and 10 (17%) control subjects. When the association of PC-1 121Q allele and the risk of suffering from CHD were assessed within the DM group in a binary logistic regression model adjusting for age and sex, PC-1 121Q allele carriers had a 76% lower risk (OR 0.24; 95% CI: 0.08-0.67, P = 0.006) for developing CHD compared to subjects who exhibited PC-1 wild-type.
  
  
  CONCLUSIONS
  The prevalence of the PC-1 121Q allele was significantly higher in type 2 diabetic patients who suffered from CHD, compared to type 2 diabetic patients without CHD. However, after a binary logistic regression model analysis, adjusting for age and sex., PC-1 121Q allele carriers had a 76% lower risk (OR 0.24; 95% CI: 0.08-0.67, P = 0.006) for developing CHD compared to subjects who exhibited PC-1 wild-type. Since these data were cross-sectional, the potential patient selection and survival bias, as well as community underdiagnosis of DM and CHD, could most likely substantially underestimate the genetic influence.
authors.affiliation: Clinic of Cardiovascular Diseases, Clinical Centre, Faculty of Medicine, Nis, Serbia.
authors.forename: Gordana
authors.initials: G
authors.lastname: Lazarevic
authors.forename: Maja
authors.initials: M
authors.lastname: Milojkovic
authors.forename: Ivan
authors.initials: I
authors.lastname: Tasic
authors.forename: Stevo
authors.initials: S
authors.lastname: Najman
authors.forename: Slobodan
authors.initials: S
authors.lastname: Antic
authors.forename: Vladisav
authors.initials: V
authors.lastname: Stefanovic
mesh_terms: D000483:Alleles; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D003430:Cross-Sectional Studies; D004247:DNA / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009391:Nephelometry and Turbidimetry; D009765:Obesity / Q000150:complications / Q000453:epidemiology / Q000235:genetics; D050177:Overweight / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D010727:Phosphoric Diester Hydrolases / Q000097:blood / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D015995:Prevalence; D011379:Prognosis; D011755:Pyrophosphatases / Q000097:blood / Q000235:genetics*; D012307:Risk Factors; D015022:Yugoslavia / Q000453:epidemiology
chemical_list: D004247:DNA; D010727:Phosphoric Diester Hydrolases; C065962:ectonucleotide pyrophosphatase phosphodiesterase 1; D011755:Pyrophosphatases